MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition.

Dispensary 52

Dispensary Patients Environment Conditions 52

Cannabis Law Report

JANUARY 24, 2020

Currently very limited in its nature, MCAP is only open to patients with spasticity associated with multiple sclerosis and intractable nausea and vomiting associated with chemotherapy that doesn’t respond to conventional treatments. Additionally, severe refractory (treatment-resistant) epilepsy also qualifies.

Oil 59

Oil Epilepsy Conditions Treatment 59

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. To fully understand this definition, you also need to know two other legal definitions: Medical marijuana treatment center. What law legalized medical marijuana in Florida?

Law 126

Law Marijuana Patients Treatment 126

Canna Law Blog

APRIL 27, 2020

In this case, letters were issued to CBD companies claiming that their products could treat medical conditions, including opioid addiction, or serve as an alternative to opioids. Opioid addiction is a real problem in our country, and those who are addicted need to seek out proper treatment from a health care provider.

CBD 58

CBD Topical Oil Treatment 58

The Joint Blog

JUNE 19, 2023

This growth is fueled by the increasing acceptance of CBD as a natural and safe alternative to traditional veterinary treatments, as well as the growing body of research supporting its use in managing various health conditions in animals. By reducing inflammation, CBD can help improve your pet’s overall health and well-being.

Pets 29

Pets CBD Research and Development Safety 29

The Blunt Truth

DECEMBER 4, 2019

Specifically, the bill proposes to make it unlawful for an employer to take adverse action against an applicant or employee who is a qualified patient using medical marijuana consistent with state law, unless the position held or sought is one involving “safety-sensitive job duties.” The dispensing of pharmaceuticals.

Marijuana 65

Marijuana Safety Packaging State Laws 65

Cannabis Law Report

SEPTEMBER 22, 2022

AB 1646 – Cannabis Packaging: Beverages. AB 1646 authorizes cannabis beverages to be packaged in containers of any material that are clear or any color. AB 1894 – Integrated Cannabis Vaporizer: Packaging, Labeling, Advertisement, & Marketing. AB 1706 – Cannabis Crimes: Resentencing. AB 2568 – Cannabis: Insurance Providers.

Law 52

Law Events Packaging Pets 52

Cannabis Law Report

FEBRUARY 17, 2022

Mycotoxins are contaminants that licensees are required to screen for to uphold public health, safety, and welfare. The Commission continues to actively monitor the licensee’s compliance with the conditions of the Order including the licensee’s Standard Operating Procedures relative to product recalls and notification to the public.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. The analysis explores barriers to access, civil protections, affordability, health and social equity, and product safety, as well as penalties for detrimental policies. ASA examines medical cannabis law efficacy.

Access 98

Access Law Patients Programs 98

Cannabis Law Report

JULY 19, 2021

Psychedelic medicine is a rapidly growing area and could be potential breakthrough therapeutics globally for psychiatric conditions such as depression, post-traumatic stress disorder (PTSD) and addiction. Extensive early phase experience with appropriate safety oversight and early phase clinic.

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98

Cannabis Law Report

DECEMBER 6, 2019

Specifically, the bill proposes to make it unlawful for an employer to take adverse action against an applicant or employee who is a qualified patient using medical marijuana consistent with state law, unless the position held or sought is one involving “safety-sensitive job duties.” The dispensing of pharmaceuticals.

Marijuana 45

Marijuana Safety Packaging Law 45

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma’s objective is to create and leverage a proprietary drug development platform in collaboration with an artificial intelligence and machine learning group to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific disease states and conditions.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Veriheal

MARCH 11, 2021

The labels are often packaged like common products which can be found in the average household and may even state that it is not safe for consumption. Remember that these drugs are being made with the least concern for your health and safety. Synthetic Cannabinoids. Synthetic Cathinones . Synthetic Phenethylamines. Induced depression.

Cannabinoids 52

Cannabinoids DEA Terpenes Packaging 52

The Joint Blog

JANUARY 26, 2021

CBD treats chronic pain, depression, sleep disorders, anxiety, inflammation, and some neurological conditions. Thus, you can treat most conditions with ten times lower CBD doses. The good thing about CBD is that its side effects are infrequent and don’t require treatment. Why does it matter regarding safety? Sleepiness.

Oil 26

Oil CBD Chronic Pain Extraction 26

The Joint Blog

MAY 19, 2020

The truth is that cannabis is, for many people, an extremely important treatment that’s set to become mainstream. Marijuana Clinics: Since marijuana is Schedule I, nobody is allowed to ‘prescribe’ it, but they can ‘certify’, ‘authorize’, or ‘recommend’ its use for certain conditions. Over half the states in the U.S.

Business 41

Business Oil Education Seed-To-Sale 41

Cannabis Law Report

AUGUST 19, 2019

It is important to remember that even if the end product is an exempt product or a CBPM, it is still an offence under the Act to cultivate the cannabis plant without a Home Office cultivation licence, which will be granted only if certain conditions are met. The Regulations define a CBPM as a preparation or product that. (a)

Environment 45

Environment Food Seed-To-Sale Medicine 45

Cannabis Law Report

JULY 30, 2019

The same cannot be said for opioid treatment. Florida has existing integrated quality and safety control components due to the regulation that all Florida cannabis products are Phylos Certified. and one in China, for quality, health and safety issues: such as heavy metal, insecticide, pesticide levels. As for the future?

Marijuana 40

Marijuana Education Patients Research and Development 40

CannaMD

MAY 14, 2020

CannaMD has contacted Florida’s leading medical marijuana treatment centers (MMTCs) , who say they’re now just waiting on the Department of Health to issue rules regarding packaging and other essential requirements. Safety of production and packaging. Risks of over-consumption and accidental ingestion.

Edibles 105

Edibles Marijuana THC Vaping 105

Cannabis Law Report

SEPTEMBER 23, 2019

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. These designations indicate that psychedelics may represent substantial improvements over existing treatments for mental health conditions.

Law 105

Law Research and Development Therapy DEA 105

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). Two strengths of INM-755 cream will be evaluated in 22 adult subjects over a 14-day treatment period. Most types of epidermolysis bullosa are inherited. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45

Safety CBD Clinical Trials Oil 45

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Otherside Farms

DECEMBER 10, 2019

CBD is additionally being investigated as an available treatment for pain, anxiety, and schizophrenic psychosis symptoms in humans. The CHF hopes that this can be the initial study to achieve scientific knowledge on the use of CBD in animals, particularly dogs with this condition. How will CBD affect Dogs? Risks of CBD Oil for Dogs.

Oil 18

Oil CBD Pets Blood Pressure 18

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). Two strengths of INM-755 cream will be evaluated in 22 adult subjects over a 14-day treatment period. Most types of epidermolysis bullosa are inherited. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

The Cannigma

DECEMBER 22, 2021

At the moment, you said that they could potentially add more conditions. What conditions, or indications can doctors prescribe for in Israel at the moment? IR: Well, today, there is a closed list, basically, of conditions. It has the – you assume safety, at least to a certain level. We have autism and epilepsy.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Veriheal

DECEMBER 22, 2022

Andy Beshear (Democratic Party) outlined a list of conditions that state residents must meet to access medicinal-grade cannabis starting on Jan. Due to a lack of regulations, concerns have grown regarding the safety of delta-8, which is not currently federally scheduled. One of those executive orders signed by Gov.

THC 62

THC Conditions Policy Packaging 62

Cannabis Law Report

DECEMBER 19, 2019

Requests feedback on potential changes to address public health and safety issues. Issue 1: Options for addressing public health and safety concerns. Do read to the bottom to learn more about Sen Crapo and substance abuse… DECEMBER 18, 2019. Chairman Crapo Outlines Concerns with Cannabis Banking Legislation.

Banking 71

Banking Legalization Safety Research and Development 71

Cannabis Law Report

OCTOBER 17, 2019

Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state. Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. alcoholic beverages, caffeine, and tobacco).

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

JANUARY 21, 2019

The California treatment of pension income is generally the same as federal treatment. b) All required records shall be prepared and retained in accordance with the following conditions: Records shall be legible; and. . (2) BCC has provided guidance with respect to the retention of required accounting records in Sec.

Seed-To-Sale 40

Seed-To-Sale Business Compliance Compliance 40

Cannabis Law Report

MAY 14, 2022

Senator Patty Murray (D-WA) is currently leading a push to include it in a sweeping package intended to help resolve the country’s ongoing supply chain issues. NY – New York Governor Kathy Hochul announced that the state’s Cannabis Control Board approved 52 adult-use conditional cultivator licenses across the state. Dentons Speaks.

Banking 52

Banking Recreational Research and Development Cannabis 52